Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Zakria

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Dermatology Online Journal|October 31, 2025
How Janus kinase selectivity impacts efficacy and safety of abrocitinib for atopic dermatitis: an expert consensus panelAngela Rosenberg, Danny Zakria, Lauren DeBusk, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.
Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.
The Journal of Clinical and Aesthetic Dermatology|February 5, 2026
Optimal Use Recommendations and Stewardship Principles with Oral Antibiotics in Acne Vulgaris Management: An Expert Consensus PanelAngela L Rosenberg, Milaan Shah, James Q Del Rosso, et al.
Journal of Drugs in Dermatology : JDD|November 9, 2023
Telemedicine Versus Teledermatology Usage and Perception Among US-Based Physicians: A Survey StudyMaham Ahmad, Justin W Marson, Graham H Litchman, et al.
Journal for Immunotherapy of Cancer|July 7, 2022
Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanomaInes Pires da Silva, Danny Zakria, Tasnia Ahmed, et al.
BMC Cancer|January 6, 2022
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanomaGeorgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Dermatology Online Journal|October 31, 2025
How Janus kinase selectivity impacts efficacy and safety of abrocitinib for atopic dermatitis: an expert consensus panelAngela Rosenberg, Danny Zakria, Lauren DeBusk, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus PanelJoshua Burshtein, Milaan Shah, Danny Zakria, et al.
Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.
The Journal of Clinical and Aesthetic Dermatology|February 5, 2026
Optimal Use Recommendations and Stewardship Principles with Oral Antibiotics in Acne Vulgaris Management: An Expert Consensus PanelAngela L Rosenberg, Milaan Shah, James Q Del Rosso, et al.
Journal of Drugs in Dermatology : JDD|November 9, 2023
Telemedicine Versus Teledermatology Usage and Perception Among US-Based Physicians: A Survey StudyMaham Ahmad, Justin W Marson, Graham H Litchman, et al.
Journal for Immunotherapy of Cancer|July 7, 2022
Efficacy and safety of anti-PD1 monotherapy or in combination with ipilimumab after BRAF/MEK inhibitors in patients with BRAF mutant metastatic melanomaInes Pires da Silva, Danny Zakria, Tasnia Ahmed, et al.
BMC Cancer|January 6, 2022
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanomaGeorgia Sofia Karachaliou, Rached Alkallas, Sarah B Carroll, et al.
Pageof 5